z-logo
Premium
Effect of hemodialysis on the plasma levels of clofarabine
Author(s) -
Steinherz Peter G.,
Shukla Neerav,
Kobos Rachel,
Latcha Sheron
Publication year - 2010
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.22458
Subject(s) - clofarabine , hemodialysis , medicine , dialysis , urology , gastroenterology , leukemia , cytarabine
Clofarabine, a nucleoside analogue for treatment of relapsed leukemia, is 50–60% excreted in urine. Clofarabine has not been studied in patients on hemodialysis. We measured levels in one patient in acute renal failure. Prior to dialysis, 43 hr after a 40 mg/m 2 infusion, plasma concentration was 139 ng/ml. One hour after begining hemodialysis, a 20 mg/m 2 infusion began. Plasma concentrations were 84.2, 81.1, and 88.0 ng/ml while the dialysis and clofarabine infusion occurred simultaneously. Post‐dialysis, while the clofarabine was still infusing, the level was 95.8 ng/ml. Hemodialysis does decrease clofarabine levels, but given its large volume distribution, hemodialysis may not be effective for clofarabine overdose. Pediatr Blood Cancer 2010;55:196–198. © 2010 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom